Background-Vitamin D deficiency in humans is frequent and has been associated with
Introduction
Vitamin D is a misnomer. The body produces this hormone through precursors with final hydroxylation to the most active metabolite 1,25-dihydroxycholecalciferol (1, .
Vitamin D is ingested with food or synthesized from the precursor 7-dehydrocholesterol which is then photochemically converted in the sunlight-exposed skin into cholecalciferol (vitamin D3).
Active 1,25-VitD3 is generated by two hydroxylation steps: 25 -hydroxylation in the liver followed by 1 -hydroxylation in the kidney. The latter reaction is particularly rate limiting and thus the effective concentration of 1,25-VitD3 is much lower than that of vitamin D3 or 25-hydroxy-vitamin D3. By a positive feedback loop, 1,25-VitD3 induces the 24-hydroxylase expression. As 1,24,25-trihydroxy-VitD3 is water soluble and cleared by the kidney, this pathway limits the effects of the hormone and 24-hydroxylase expression can be used as a marker for the biological activity of 1,25-VitD3. Unless vitamin D is supplemented, intake with food is usually insufficient and thus endogenous production contributes significantly to plasma levels. This leads to vitamin D deficiencies in up to 70% in some population groups in which sunlight exposure is low due to modern life style, clothing and few sunshine hours during winter 1;2 .
The best characterized vitamin D effects are enhanced intestinal calcium absorption and an increase in plasma calcium level. The biological effects of 1,25-VitD3, however, extend far beyond calcium metabolism. By controlling gene expression through the nuclear vitamin D receptor (VDR), 1,25-VitD3 has been suggested to limit inflammation and cancer and thus lack of vitamin D has been associated with auto-immune disorders like multiple sclerosis or neoplastic diseases 3 . In the cardiovascular system, a low vitamin D status is inversely associated with blood pressure in blacks 4 and increased renin-angiotensin II activity in mice 5 . Vitamin D expression. As 1,24,25-trihydroxy-VitD3 is water soluble and cleared by the kid dn n ney, y y t thi hi his s s pathway limits the effects of the hormone and 24-hydroxylase expression can be used as a ma mark rk rker er er f f for or r t t the he h b bio io iol lo logical activity of 1,25-VitD3. Un Unless vitamin D D D is su su up pp pplemented, intake with f fo ood d d is usually y in in insu uff ff fic ic i ie ie ent nt nt a a and nd nd t thu hu us s s en en nd do ogeno no nous p pr pro odu uc ucti tion on n c c con ont tri ib but ute es s sig ign n nif if fic ican an ntl tl ly y y to to o p p pl la lasm sm sma a e eve ve vels ls s. . Th This is s l l lea ead ds s t t to o v vi ita a ami min D D D de de defi fi fici c cien en nci ci cies es es i in n up up u t to o 70 0 0% % % in in in som om ome e e po po popu pu ula ati tion on n g g gro ro r up up ups s s in n n w w whi hic ch ch unlight exp pos os sur ur ure e is is is l low ow ow d due ue u t t to mo mo m de de d rn n n l lif if ife e e st st tyl yl yle, e, e, c c clo lo oth thin in ing g g an an and d d fe fe fe f f f f w w su su suns ns nshi hi hine ne ne h h hou ou ours rs r d d dur u u ing 4 has also been suggested to delay the development of heart failure and potentially myocardial infarction 6 . Furthermore, epidemiologic evidence links low vitamin D status to an increased risk for cardiovascular disease [7] [8] [9] . Although these observations are still very controversial 10 , they have attracted considerable attention in cardiovascular research to study the effects of this hormone 11 .
Little is known about the role of vitamin D in endothelial cell biology. Initial data suggested that high doses of vitamin D inhibit endothelial cell migration which could be used to treat tumor angiogenesis 12 . Whether physiologic concentrations of active vitamin D, however, have an effect on angiogenesis is elusive. Considering the anti-inflammatory and prodifferentiating effects of vitamin D, we hypothesized that the hormone promotes vascular regeneration. To address this, we subjected mice to the carotid artery injury model and femoral artery ligation. Furthermore, we investigated the effect of vitamin D supplementation on circulating angiogenic myeloid cells (AMCs) both in a mouse model of type 1 diabetes as well as in healthy volunteers.
Methods
An expanded methods section is available in the Online Supplemental Material at http://circ.ahajournals.org .
Experimental animals and animal procedures
All experimental procedures were approved by the local governmental authorities (approval numbers: F28/14, F28/30) and were performed in accordance with the animal protection guidelines exclusively in male mice. 15 . The generation and general characterization of VDR flox/flox 16 and SMMHC-CreERT2 mice 17 has been described previously. Cdh5-CreERT2 mice 18 were kindly provided by Ralf Adams, MPI Münster. Activation of CreERT2 was achieved by tamoxifen (40 mg/kg dissolved in autoclaved sunflower oil injected intraperitoneally on 3 consecutive days followed by a "washout" phase of 2 weeks. Diabetes was induced by streptozotocin injection. Carotid artery injury was performed by the electric injury model and the area of injury was stained by Evans blue or lectin staining. Hind limb ischemia was produced by femoral artery ligation and angiogenesis was determined from laser Doppler imaging of skin perfusion and capillary density measurements.
VitD3 was supplemented as the active 1 ,25-Dihydroxy-vitamin D3 (1,25-VitD3, 100ng/kg/day) dissolved in a solvent mixture of water, propylene glycol and ethanol in a 5:4:1 ratio.
FACS analyses of angiogenic myeloid cells (AMCs)
Circulating AMCs were measured in the mononuclear cell fraction of the blood by FACS counted and stained as CD45, CD117, Sca-1 and Flk-1 positive cells.
Vitamin D treatment in healthy volunteers
A pilot study in 6 healthy volunteers (4 male, 2 female, age 32.5 ± 4.9 years, mean ± SD) who 
Statistical analysis
Unless otherwise indicated, data are given as means ± standard error of mean (SEM). For the individual statistical tests use, please see the expanded material and methods section. A probability value <0.05 was considered significant.
Results

Vitamin D3 increases the number of circulating angiogenic myeloid cells in humans
To address whether 1,25-VitD3 could have a positive effect on factors promoting vascular repair in humans, healthy volunteers were treated with vitamin D3 (4000 IU, orally once a day) and blood was drawn prior, during and after the 6 weeks treatment course. The treatment induced a significant increase in the levels of the vitamin D3 metabolite 25-hydroxy-vitamin D3 and importantly also doubled the plasma concentration of active 1,25-VitD3 (Fig. 1A&B) .
Importantly, the number of CD45-CD117+ Sca1+ Flk1+ cells, denoted as angiogenic circulating myeloid cells (AMCs) more than doubled during VitD3 treatment of humans (Fig. 1C) . To correlate this finding with the biological activity of 1,25-VitD3, the expression of 24-hydroxylase was determined in myeloid cells obtained from the peripheral blood during the trial.
The enzyme was almost undetectable prior to treatment but was massively induced by in vivo vitamin D3 (Fig. 1D) . After termination of the treatment, the level of active 1,25-VitD3 slowly decreased as did the number of circulating AMCs and the 24-hydrolase expression. This suggests that the effects observed during the study were related to vitamin D3 therapy.
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1,25-VitD3 promotes endothelial regeneration in mice
To determine whether 1,25-VitD3 indeed promotes endothelial regeneration, mice were treated with 1,25-VitD3 (100 ng/kg/day) for five days and were subsequently subjected to carotid artery electric injury. Although this approach only increased the plasma levels of 1,25-VitD3 by approximately 2.5 fold, it elevated the number of CD45-CD117+ Sca1+ Flk1+ cells, denoted as angiogenic circulating myeloid cells (AMCs) in blood and bone marrow and more than doubled the number of colony forming units (CFUs) from the spleen ( Fig. 2A-D) . Importanly, 1,25-VitD3 also greatly enhanced endothelial regeneration, as evidenced by a significantly lower
Evans blue positive and lectin negative area in the injured carotid artery ( Fig. 2E-F ). Also when a higher dose of 1,25-VitD3 was administered (1 μg/kg/d) for the same duration or when 1,25-VitD3 was given every other day over 4 weeks this healing effect was observed (Fig. S1A&B) .
A single injection of 1,25-VitD3 (1 μg/kg/d) at the time of carotid injury failed to affect regeneration( Fig. S1C) , indicating that some pretreatment is required for the beneficial effects of 1,25-VitD3. Importantly, also 22-oxocalcitriol, a pharmacological 1,25-VitD3 analogue which is thought to have limited effects on plasma calcium levels and thus a reduced risk of extraskeletal calcification was similarly effective as 1,25-VitD3 in promoting reendothelialization (Fig. 2G) .
1,25-VitD3 restores vascular regeneration in diabetic mice
Diabetes patients are frequently affected by vitamin D deficiency 19 and the systemic inflammation in diabetes has been linked to functional vitamin D shortage 20 . As vascular dysfunction is the most important complication of diabetes, we hypothesized that diabetic vasculopathy will be alleviated by 1,25-VitD3 supplementation. Indeed, in streptozotocin (STZ) type 1 diabetic mice, carotid artery re-endothelialization and CFU formation were greatly reduced (Fig. 3A&B) . Although vitamin D plasma levels, as expected, were normal in type Ia higher dose of 1,25-VitD3 was administered (1 μg/kg/d) for the same duration n o o or wh wh when en en 1 1 1,2 ,2 ,25-5-VitD3 was given every other day over 4 weeks this healing effect was observed (Fig. S1A&B) .
A A si si ing ng ngle le le i i inj nj njec ec ction on n o of f 1,25-VitD3 (1 μg/kg/d) at th th the t time of caroti id d d inju ju ury ry ry failed to affect e ege e ene n ration(Fi Fi ig g g. S S S1C 1C C), , i i ind nd ndic ic ica at atin ing g g th th t a at t s s som me e p p pret tre rea atme me ment nt i i is r req eq qui uire red d d fo f f r r r th th he e e b be bene ne efi fi fici ci cial al a e e eff f ffec ec cts s s of (Fig. S2) , 1,25-VitD3 supplementation had a beneficial effect so that CFU formation was increased by 1,25-VitD3 and vascular healing was completely normalized to the level obtained in control animals (Fig. 3A&B) . Encouraged by this finding, vascular regeneration in the femoral artery ligation model was determined. In normal C57BL/6 mice basal angiogenesis was very strong but basically ablated by diabetes as determined by laser Doppler imaging and capillary density measurements. Remarkably, 1,25-VitD3 treatment completely restored the normal angiogenic response in these highly vascular dysfunctional animals ( Fig. 3C-F ). These data indicate that 1,25-VitD3 can revert vascular dysfunction and that 1,25-VitD3 is a candidate to restore angiogenesis in diabetes. Although the benefit of 1,25-VitD3 in diabetic mice is greater than that in healthy mice, it can, however, not be inferred for the present data that diabetes is a situation of functional vitamin D-deficiency.
CXCR4-positive myeloid cells mediate the regenerative effect of 1,25-VitD3
The positive effect of 1,25-VitD3 on re-endothelialization could be the consequence of a direct effect on endothelial cells or could be mediated by changes in the environment promoting endothelial migration in a paracrine manner. To distinguish between these possibilities, tissue specific knockout mice of the vitamin D receptor (VDR) were generated. The regenerative effect of 1,25-VitD3 was lost in mice lacking the VDR in LysM-positive myeloid cells (Fig. 4A) . In contrast, deletion of VDR in endothelial or smooth muscle cells performed in tamoxifeninducible tissue-specific cre-deleter strains (Fig. S3 ) had no effect on regeneration (Fig. 4B&C ).
To exclude a potential role of platelets in the process, mice were made thrombocytopenic by treatment with anti-CD42 antibody and although this lowered the platelet count by more than 90% it did not affect 1,25-VitD3-stimulated vascular regeneration (Fig. S4A&B) . T The e e po p sitive e eff ff fe e ect t t of of f 1,2 ,2 25 5-5-Vi V Vit tD tD3 3 on on n r re-e-e end do ot th heli ia al li iza at ti tio on on c c co ou uld ld b be e th th he e e c con ons se sequ quen en nce ce e o of f f a a a d di dir r rec c ct ef ffe fe fect ct t o o on n en en ndo do d th the e eli ia ial l c c cel ll ls s or r c cou ou uld ld ld b b be e me me medi di dia a ated ed ed b by y c chan an ange ge ges s s in n n t th h he e e env nv n i ir iro on nme me ment nt nt p p pro ro rom mo mot t ting ng ng endothelial mi mi migr gr grat at tio io ion n in in in a p p par ar aracr cr crin in ne e e ma ma ann nn nner er er. . To To To d d dis is isti ti ting ngui ui uish sh sh b b be e etw tw twee e en n n th th thes es ese e e po po p ss ss s ib ib ibil il ilit it itie ie i s, tissue 9 of polymorphonuclear neutrophils (PMN) by anti-PMN antibody had no effect on 1,25-VitD3-induced re-endothelialization whereas clodronate, which depletes predominately macrophages and related cells prevented the 1,25-VitD3-induced re-endothelialization ( Fig. S4C-F 
SDF1 mediates the regenerative effect of 1,25-VitD3
CXCR4 is the receptor for SDF1, making this chemokine a potential mediator of the 1,25-VitD3 effects. Indeed, SDF1 mRNA expression was increased in the carotid artery of 1,25-VitD3 treated mice already within 24 hours after injury, whereas injury alone or 1,25-VitD3 alone had no effect on SDF1 expression (Fig. 4E) . To address whether tissue-resident cells mediate this effect, experiments were repeated in isolated murine vascular segments. Similar to the in vivo setting, ex vivo stimulation with a fairly low concentration of 1,25-VitD3 (10 nmol/L) increased SDF1 mRNA only in vessels which were previously injured ex vivo by detergent application (Fig. 4F) . The increase in SDF1 mRNA also resulted in protein formation and secretion of the chemokine as detected by a significant increase in SDF1 protein in response to 1,25-VitD3 in the conditioned medium of the injured vessels (Fig. 4G) . To test whether SDF1 released from the 1,25-VitD3 treated injured vessel mediates the chemotatic stimulus on myeloid cells, Boyden ef ffe fe fect ct ts s. s I Ind nd dee ee eed, d, S S SD DF DF1 1 m mR mRNA NA A e exp xp xpre re ress ssi io ion n n wa wa was in in incr cr re ea ase e ed d in in in t t the e e c ca a arot ot otid id i a a art t ter ery y y of of f 1 1,2 ,2 ,25 5-5-V Vi itD D D3 3 reated mice a a alr lr lrea ea eady dy dy w w wit it thin n n 24 24 24 h h hou ou ours rs rs aft ft fter er r i inj nj n ur ur ury y y, , , wh wh wher e ea ea eas s in in inju ju jury ry ry alo lo lone ne ne or or or 1 1 1,2 ,2 , 5-5-5 Vi Vi VitD tD D3 3 3 alone had chamber experiments were performed with conditioned medium prepared from vascular segments. Medium conditioned with injured 1,25-VitD3 treated vessels had the greatest chemotactic effect (Fig. 4H) and importantly, the chemotactic effect was blocked by a SDF1 neutralizing antibody (Fig. 4I) . To directly visualize this chemotactic effect in vivo, homing was studied. Bone marrow mononuclear cells were labeled ex vivo and injected into mice. Without injury no positive cells were observed in the carotid artery, whereas injury induced homing and this effect was stimulated by 1,25-VitD3 pretreatment (Fig. 4J) .
Collectively, these data demonstrate that tissue-resident cells express and release SDF1 upon the combined stimulation of injury and 1,25-VitD3 which then attracts AMCs to the vessel.
Myeloid cells are the source of injury and 1,25-VitD3-induced SDF1 production
To identify the cellular sources of SDF1, VDR-conditional knockout mice were studied.
Interestingly, an increase in SDF1 plasma level in response to 1,25-VitD3 was not observed in VDR flox/flox-mice crossed with the LysM-Cre deleter strain ( (Fig. 6E&F) . Collectively, these data suggest that 1,25-VitD3 acts through HIF1 in LysM-positive cells to induce SDF1.
1,25-VitD3 induces HIF1
Cytokines and injury are known to increase HIF1 protein by attenuating HIF1 protein degradation 23 . The fact that 1,25-VitD3 had an additive effect to cytokines / injury suggests that the hormone acts through a different mechanism. Indeed, 1,25-VitD3 increased the HIF1 mRNA expression of human AMCs under basal conditions as well as after cytokine priming ( on HIF1 promoter activity was tested. In cytokine-primed human AMCs transiently transfected with a luciferase-reporter construct carrying up to 821 base pairs upstream of the transcription start site, 1,25-VitD3 induced an approx. 8 fold increase in reporter activity (Fig. 6H) . In order to obtain direct proof of an activation of the vitamin D-receptor on the HIF1 promoter chromatin immuno-precipitation (ChIP) was performed. Due to the limited availability of human AMCs and the difficulties associated with their transfection, these experiments were carried out in cytokine-primed HEK293 cells transiently transfected with the VDR and the retinoid X receptor, which acts in concert with the VDR 24 . In these experiments, 1,25-VitD3 increased the recovery of HIF promoter regions around predicted vitamin D responsive elements (VDRE) at nucleotides 808 to 435 upstream of the transcriptional start site, whereas recovery upstream or downstream of the nucleotides 808-435, which did not contain a VDRE, was not increased (Fig. 6I) . To ci ci irc c cu ulating AM AM MCs Cs Cs bot ot oth h h in in in h h hea ea alt lt lthy hy hy h h hum um uman an ns s mi mi mic ce ce and nd nd in n mi mi mice ce ce w w wit it th h h ca ca caro ro roti ti tid d d inju ju ury ry ry. . We We We d d dem em emon on onst st stra ra r te h h hat at a 1 1 1,2 ,25-Vi VitD tD tD3 3 pr pr prom omo otes es va a ascu cu cula lar r re r reg g gen ne nera ratio on on in n n h hea ea alt lt thy hy m mic ice e an n nd re re est tor ore e es n n nor orm ma mal l l va a as sc cul ula a ar or hypoxia increases in Hif1 mRNA have basically no effect on HIF1 protein levels 23 .
It is a potential weakness of our study that we did not identify in detail the nature of the Our study contrasts early observations suggesting that vitamin D limits angiogenesis 12 .
VDR directly binds to its promoter. This also explains why in acute experiments s in in t the he e a a abs bs bsen en ence c of cytokines 1,25-VitD3 had little effect on SDF1: Without a stabilizing signal like inflammation or r h h hyp yp ypo ox oxia ia ia i i inc ncre eas as ases es in Hif1 mRNA have basic c ca al a l ly y no effect on n HI H H F1 F1 1 p protein levels 23 .
The context of that study, however, was different, since a tumor environment and high doses of 43. Aplin AC C, , , Li Li L gr gr gres es e ti ti i G G G, Fo Fo Foge ge g l l l E, E, E Z Z Zor r rzi zi z P P P, , , Sm Sm Smit ith h h K, K, K, N N Nic ic icos os osia ia ia R R RF. F F R R Reg eg egul ul u at at atio io ion n of of of a a ang ng ngio io i genesis, mu mura ral l ce cell ll r rec ecru ruit itme ment nt a and nd a adv dven enti titi tial al m mac acro roph phag age e be beha havi vior or b by y To Toll ll l -lik ike e re rece cept ptor ors s An Angi giog ogen enes esis is s and temperature and to maintain a constant body temperature, mice were exposed to infrared light for 10 minutes before laser Doppler scans. During the scan, mice were positioned supine on a heating pad with their legs stretched and fixed. To determine capillary density, cross-sections of adductor and semimembranous muscles embedded in Tissue Tek (Sakura, Heppenheim, Germany) were stained. After fixation in phosphate buffer (100 mmol/L, pH 7.3) containing 4% formalin the tissue was blocked with 3% bovine serum albumin and permeabilized with 0.5% Triton X-100 followed by incubation with anti-CD31 (BD Pharmingen, Heidelberg, Germany) and anti-laminin (Abcam, Cambridge, UK) and imaged by confocal microscopy.
Active vitamin D supplementation 1α,25-Dihydroxy-vitamin D3 (1,25-VitD3, 100 ng / kg / day) was dissolved in a solvent mixture of water, propylene glycol and ethanol in a 5:4:1 ratio. For the carotid artery injury model, 1,25-VitD3 or solvent were injected intraperitoneally in a series of 5 days followed by electric-injury. For the femoral artery ligation model, animals received additional injections every other day after the operation.
FACS analyses of angiogenic myeloid cells (AMCs)
Murine circulating AMCs were determined in the blood obtained by cardiac puncture in heparinized syringes. Human AMCs were isolated from whole blood of healthy donors. Plasma was obtained by centrifugation at 800 g for 10 minutes. The remaining blood fraction was diluted with 1 mL PBS containing 0.5% BSA and 2 mmol/L EDTA and was overlaid on top of 3 mL LSM 1077 lymphocyte separation medium (PAA Laboratories, Pasching, Austria) and subjected to density gradient centrifugation (800 g, 20 minutes). Murine bone marrow-derived mononuclear cells were obtained by flushing the femurs with 1 mL PBS containing 0.5% BSA and 2 mmol/L EDTA and subsequent density gradient centrifugation as mentioned above. Mononuclear cells were counted and stained for CD45, CD117, Sca-1 and Flk-1 surface expression using PE, APC, FITC or eFluor® 605NC-labeled antibodies in a dilution of 1:100 in PBS buffer after blocking non-specific Fc receptor binding. CD45, CD117 and Flk-1 antibodies were purchased from BD Pharmingen (Heidelberg, Germany), while the Sca-1 antibody was purchased from eBioscience, San Diego, CA. Gating strategies were designed using fluorescence minus one (FMO) controls and samples were acquired using a LSRIIFortessa flow cytometer and FACSDiva software 6.0 (BD Biosciences, Heidelberg, Germany).
Colony forming units (CFU)
Murine spleens were isolated, homogenized and filtered through 100 µm cell strainer (BD Falcon, Franklin Lakes, USA),followed by subsequent density gradient centrifugation as mentioned above. 1x10 Determination of vitamin D, its metabolites and cytokine plasma-level ELISA kits from IDS were used to determine the plasma concentrations of 1,25-VitD3 and 25-hydroxyvitamin D3 according to the instructions contained in the kit. SDF-1 plasma level was determined by ELISA-kits purchased from R&D following the manufacturer's instructions.
Cell culture and transfection
White blood cells were plated in a density of 4x10 6 per cm² on fibronectin-coated plates in endothelial growth medium (EGM) containing 2% fetal calf serum (FCS). Medium was changed every other day until day 7. For RNA induction or ELISA experiments, angiogenic myeloid cells (AMCs) or THP1 macrophages were treated with DMSO (Sigma-Aldrich, Munich, Germany) or 1,25-VitD3 (10 nM; Sigma-Aldrich, Munich, Germany) for 24 hours followed by the supplemental incubation with TNFα (10 ng/mL; Peprotech, Hamburg, Germany) and Il1β (10 ng/ mL; Peprotech, Hamburg, Germany) for 16 hours. For inhibition of hypoxia inducible factors, acriflavine (10 µmol/L) was used for 16 hours (Sigma-Aldrich, Munich, Germany). AMCs were identified by their ability to stain positive for Ulex europaeus lectin and to take up 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyaninelabeled acetylated low density lipoprotein (DilAc-LDL). For this, cells were incubated with DilAc-LDL (2.4 μg/mL) at 37°C for 1 hour and subsequently exposed to fluorescein-5-isothiocyanate (FITC)-labelled Ulex europaeus agglutinin I (lectin, 10 μg/mL; Sigma-Aldrich, Munich, Germany) for 1 hour. Double positive cells were judged as AMCs and 99% of all cells in the culture were positive for both dyes. Murine blood AMCs were isolated and cultured in a similar way.
Homing experiments
Bone marrow was obtained from the femurs of healthy, untreated donor mice. Monocytic cells were treated ex vivo with cell tracker orange (Invitrogen, Carlsbad, CA, USA) and cells (5x10 5 cells) were resuspended in 100 µL of prewarmed PBS and injected into recipient mice (i.v. via tail vein) 3 hours after the carotid artery injury. The recipient mice were sacrificed 1 day after the injury and the carotid arteries were harvest, sectioned, counter stained with DAPI and imagined by laser microscopy. The number of positive cells in 10 consecutive sections was added per artery and used for statistics.
Luciferase assay and site-directed mutagenesis
AMCs were transiently transfected with the original or Vitamin D responsive element (VDRE) mutated pGL3-HIF1α promoter (821 nt) plasmid in pGL3 with Transpass D2 according to the manufacturers protocol (New England Biolabs, Frankfurt, Germany). 24 hours after transfection cells were stimulated with DMSO or 1,25-VitD3 (10 nmol/L) for 24 hours, followed by the stimulation with TNFα (10 ng/mL) and Il1β (10 ng/mL) for 16 hours. Luciferase activity was determined with the assay kit from Promega (Mannheim, Germany) following the manufacturer's instructions in a Berthold LB9505 luminometer (Bad Wildbad, Germany) and normalized to the empty pGL3 control vector (Promega). VDREs were predicted with the aid of the JASPAR database 8 . The VDREs of the human HIF1α-promoter in the pGL3-HIF1α plasmid were mutated at sites 438 (tggatctcgag to tgTatAGGAag), 626 (aggcgcaga gtccc to agTcTcaTaTtTcc) and 648 (ccgggcac to ccT gTTac) with the Quikchange II XL Site-directed Mutagenesis Kit from Agilent (Santa Clara, USA) according to the manufacturer's protocol. For primer sequences, see supplementary table 1.
Chromatin immuno-precipitation (ChIP)
HEK293 cells were transiently transfected with pSG5 vectors expressing the retinoid x receptor (RXR) and the vitamin D receptor (VDR) 9 with Fugene6 (Roche, Mannheim, Germany) according to the manufacturer's protocol, and subsequently stimulated as indicated and subjected to ChIP as follows: Cell preparation, crosslinking and nuclei isolation was performed with the truCHIP™ Chromatin Shearing Kit (Covaris, Woburn, USA) according to the manufacturers protocol. Afterwards, the lysates were sonified with the Bioruptur Plus (10 cycles, 30 seconds on, 90 seconds off; Diagenode, Seraing, Belgium) at 4°C. Cell debris was removed by centrifugation and the lysates were diluted 1:3 in dilution buffer (20 mmol/L Tris/HCl pH 7.4, 100 mmol/L NaCl, 2 mmol/L EDTA, 0.5% Triton X-100 and protease inhibitors). After preclearing with 30 µL DiaMag protein A and protein G coated magnetic beads slurry (Diagenode, Seraing, Belgium) for 30 minutes at 4°C, samples were incubated over night at 4°C with 5 µL of anti-vitamin D receptor antibody (Sc-1008, Santa Cruz Biotechnology, Heidelberg, Germany), and 5% of the samples served as input. The VDR complexes were collected with 50 µL DiaMag protein A and protein G coated magnetic beads (Diagenode, Seraing, Belgium) for 3 hours at 4°C, subsequently washed twice for 5 minutes with each of the wash buffers 1-3 (Wash Buffer 1: 20 mmol/L Tris/HCl pH 7.4, 150 mmol/L NaCl, 0.1% SDS, 2 mmol/L EDTA, 1% Triton X-100; Wash Buffer 2: 20 mmol/L Tris/HCl pH 7.4, 500 mmol/L NaCl, 2 mmol/L EDTA, 1% Triton X-100; Wash Buffer 3: 10 mmol/L Tris/HCl pH 7.4, 250 mmol/L lithium chloride, 1% Nonidet, 1% sodium deoxycholate, 1 mmol/L EDTA) and finally washed with TE-buffer pH 8.0. Elution of the beads was done with elution buffer (0.1 M NaHCO 3 , 1% SDS) containing 1xproteinase K (Diagenode, Seraing, Belgium) and shaking at 600 rpm for 1 hour at 55°C, 1 hour at 62°C and 10 minutes at 95°C. After removal of the beads, the eluate was purified with the QiaQuick PCR purification kit (Qiagen, Hilden, Germany) and subjected to qPCR analysis. As negative control, primer targeting the β-actin promoter were used. Primers amplifying the protomor region of 25-hydroxy vitamin D 3 -24 hydroxylase (CYP24A1) served as positive control 10 . For primer sequences, see supplementary table 1.
Ex vivo vascular injury model
Mice were killed by exsanguination in deep isoflurane anesthesia and the remaining blood was then removed by transcardiac perfusion with Hanks buffer. Subsequently, the aorta was isolated, cleaned of adhering tissue under sterile condition, cut into two equal-size pieces. One was injured by perfusion with CHAPS (1% in 5% glucose). Both vessel segments were extensively washed afterwards in sterile Hanks buffer and transferred into separate wells of a 24 well plate filled with medium EGM containing 2% FCS and antibiotic without 1,25-VitD3. After 24 hours, the conditioned medium was used for Boyden chamber experiments and ELISA assays. The vessel were subjected to qRT-PCR.
Cell migration assay
Murine blood AMCs were kept in culture for 3 days. After detaching the cells with EDTA/Versene, 2x10 5 cells in endothelial growth medium (EGM) with 2% FCS were plated into the insert of a Boyden chamber (8 µm pore size). The lower part medium was supplemented with VEGF165 (50 ng/ml; R&D) or conditioned medium. EGM with 2% FCS without cytokine supplement served as negative control, reflecting basal migration. Cells were allowed to migrate for 24 hours and then migration was stopped by adding paraformaldehyde to the chamber. Cells at the upper side of the insert-membrane were removed and cells at the lower side were stained with DAPI. Positive cells in three different fields of view were counted and migration in response to the cytokines was calculated relative to basal migration. Conditioned medium was generated from mouse aortas dissected and cleaned of surrounding tissue. After preparation, the aortas were cut into 8 pieces of equal length and treated with or without CHAPS (2%) in order to remove the endothelium. Two segments were pooled and incubated in 400 µL EGM with 2% FCS with or without 1,25-VitD3 (10 nM) in a 48 well plate. Medium without aortic segments incubated on the same plate served as controls.
qRT-PCR
RNA was isolated from AMCs using the RNA Miniprep Kit (Bio&Sell, Feucht, Germany). cDNA synthesis was carried out with SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) and random hexamer primers; semiquantitative real-time PCR was performed with Fast Plus EvaGreen Master Mix for qPCR w/Low Rox (2x, 100 rxn) (Biotium, Hayward, CA, USA) in a Mx3005 cycler (Stratagene) with the indicated primers. Relative expressions of target genes were normalized, analyzed by the deltadelta-CT method and given as ratio compared to control experiments. For primer sequences, see supplemental table 1.
Vitamin D treatment in healthy volunteers
A pilot study in 6 healthy volunteers (4 male, 2 female, age 32.5 ± 4.9 years, mean ± SD) who gave informed written consent, was performed. This was part of the ViDDA1 trial (registered under EUDRACT 2010-022677-34, "Influence of high dose vitamin D substitution on humoral immunity and lymphocyte function in patients with newly diagnosed and recent onset type 1 diabetes mellitus or Addison´s disease"), which was approved by the Ethical Committee of Frankfurt Medical School. Blood was taken weekly in the morning over a period of 12 weeks and vitamin D was supplemented from week 4 to 10 by a daily oral intake of 4,000 IU cholecalciferol (Vigantol Öl, Merck Serono).
Statistical analysis
Unless otherwise indicated, data are given as means ± standard error of mean (SEM). Calculations were performed with BiAS.10.12 with the exception of the linear mixed effect model. This was processed in R 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria) utilizing the extension packed nlme 3.1-111 and multcomp 11 . The processing and the specific model accounting for inner-individual dependencies, variance heterogeneity and suitable contrasts as well as check of normality were programmed by one of the authors (E.H.). In case of multiple testing, significance correction of the linear mixed model or Bonferroni correction was applied. A p-value of <0.05 was considered as significant. Linear mixed effect model: Fig 1A, 1B, 3D Paired T-test: Fig 1C, 1D Unpaired T-test: Fig 2E, 2F , 6B, 6C, 6D, 6I, 6J, S1A, S1B, S1C, S3A, S3B, S4F, S7C, S7D Mann-Whitney test: 2A, 2B, 2C, 2D, 2F, 4G, 6H, S4A, S4D ANOVA followed by post hoc Bonferroni T-test for selected groups: Fig 3A, 3B, 4A , 4B, 4C, 4D, 4E , 4F, 4H, 4I, 4J, 5A, 5B, 5C, 5D, 6A, 6E, 6F, 6G, S2, S4B, S4, S5, S7, S7A, S7B
